Sosei Heptares Operational Highlights and Consolidated
Tokyo, Japan and Cambridge, UK, 4 August 2023 – Sosei Group Corporation (“the Company”; TSE: 4565) provides an update on operational activities and reports...
Source: globenewswire.com
Tempero Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Tempero Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Tempero Bio Today - Breaking & Trending Today
Sosei Heptares Operational Highlights and Consolidated
Tokyo, Japan and Cambridge, UK, 12 May 2023 – Sosei Group Corporation (“the Company”; TSE: 4565) provides an update on operational activities and reports...
Source: globenewswire.com
Sosei : Consolidated Financial Results for the Three Months Ended March 31, 2023 (IFRS)
Consolidated Financial Results for the Three Months Ended March 31, 2023 ... | May 12, 2023
Source: marketscreener.com
FDA clears investigational new drug application for cocaine use treatment
The FDA has given clearance to an investigational new drug application for TMP-301, a treatment for cocaine use disorders, according to the drug manufacturer. The program has also been awarded a grant expected to total $5.3 million grant over the course of 2 years from the National Institute on Drug Abuse in support of the development of TMP-301, according to a press release from Tempero Bio.
Source: healio.com
Sosei Heptares Notes its Partner Tempero Bio has Received FDA Clearance to Advance Clinical Development of TMP-301 for Treatment of Alcohol and Substa
Sosei Heptares Notes its Partner Tempero Bio has Received FDA Clearance to Advance Clinical Development of TMP-301 for Treatment of Alcohol and Substance Use Disorders TMP-301 (formerly HTL0014242) is a potent, selective, and orally available mGluR5 negative allosteric modulator (NAM) candidate discovered by So...
Source: pharmiweb.com